GB0703909D0 - Treatment of anxiety disorders - Google Patents

Treatment of anxiety disorders

Info

Publication number: GB0703909D0
Authority: GB; United Kingdom
Prior art keywords: treatment; anxiety disorders; anxiety; disorders
Prior art date: 2007-02-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0703909.2A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

NEUROPHARM Ltd

Original Assignee

NEUROPHARM Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-28

Filing date

2007-02-28

Publication date

2007-04-11

2007-02-28 Application filed by NEUROPHARM Ltd filed Critical NEUROPHARM Ltd

2007-02-28 Priority to GBGB0703909.2A priority Critical patent/GB0703909D0/en

2007-04-11 Publication of GB0703909D0 publication Critical patent/GB0703909D0/en

2008-02-14 Priority to EP08709396A priority patent/EP2129383A1/en

2008-02-14 Priority to PCT/GB2008/000504 priority patent/WO2008104734A1/en

2008-02-14 Priority to AU2008220668A priority patent/AU2008220668A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0703909.2A 2007-02-28 2007-02-28 Treatment of anxiety disorders Ceased GB0703909D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB0703909.2A GB0703909D0 (en)	2007-02-28	2007-02-28	Treatment of anxiety disorders
EP08709396A EP2129383A1 (en)	2007-02-28	2008-02-14	Treatment of anxiety disorders with minocycline
PCT/GB2008/000504 WO2008104734A1 (en)	2007-02-28	2008-02-14	Treatment of anxiety disorders with minocycline
AU2008220668A AU2008220668A1 (en)	2007-02-28	2008-02-14	Treatment of anxiety disorders with minocycline

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0703909.2A GB0703909D0 (en)	2007-02-28	2007-02-28	Treatment of anxiety disorders

Publications (1)

Publication Number	Publication Date
GB0703909D0 true GB0703909D0 (en)	2007-04-11

Family

ID=37965686

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0703909.2A Ceased GB0703909D0 (en)	2007-02-28	2007-02-28	Treatment of anxiety disorders

Country Status (4)

Country	Link
EP (1)	EP2129383A1 (en)
AU (1)	AU2008220668A1 (en)
GB (1)	GB0703909D0 (en)
WO (1)	WO2008104734A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US20060140984A1 (en)	2002-10-25	2006-06-29	Foamix Ltd.	Cosmetic and pharmaceutical foam
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en)	2007-11-30	2009-06-04	Foamix Ltd.	Foam containing benzoyl peroxide
WO2009090495A2 (en)	2007-12-07	2009-07-23	Foamix Ltd.	Oil and liquid silicone foamable carriers and formulations
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en)	2009-07-29	2017-04-11	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en)	2009-10-02	2015-06-18	Journey Medical Corporation	Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
US10398641B2 (en)	2016-09-08	2019-09-03	Foamix Pharmaceuticals Ltd.	Compositions and methods for treating rosacea and acne
GB201902580D0 (en) *	2019-02-26	2019-04-10	Healx Ltd	Treatment
GB201910755D0 (en) *	2019-07-26	2019-09-11	Healx Ltd	Treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE59209690D1 (en) *	1992-02-25	1999-06-10	Spirig Ag	Pellets containing minocycline
CA2317090A1 (en) *	1997-12-30	1999-07-08	Jari Koistinaho	Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
WO2004078111A2 (en) *	2003-03-06	2004-09-16	Ranbaxy Laboratories Limited	Extended release minocycline compositions and processes for their preparation

2007
- 2007-02-28 GB GBGB0703909.2A patent/GB0703909D0/en not_active Ceased
2008
- 2008-02-14 WO PCT/GB2008/000504 patent/WO2008104734A1/en not_active Ceased
- 2008-02-14 AU AU2008220668A patent/AU2008220668A1/en not_active Abandoned
- 2008-02-14 EP EP08709396A patent/EP2129383A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP2129383A1 (en)	2009-12-09
AU2008220668A1 (en)	2008-09-04
WO2008104734A1 (en)	2008-09-04

Similar Documents

Publication	Publication Date	Title
GB0703909D0 (en)	2007-04-11	Treatment of anxiety disorders
IL217901A0 (en)	2012-03-29	Treatment of bdnf-related disorders using laquninimod
IL208513A0 (en)	2010-12-30	Carboxamide compounds for the treatment of metabolic disorders
ZA201102640B (en)	2012-09-26	Use of scyllo-inositols for the treatment of macular degeneration-related disorders
IL194189A0 (en)	2009-08-03	Combination treatment of metabolic disorders
GB0904285D0 (en)	2009-04-22	Compounds for the treatment of metabolic disorders
EP2120930A4 (en)	2012-12-05	Use of chromium histidinate for treatment of cardiometabolic disorders
GB0904287D0 (en)	2009-04-22	Compounds for the treatment of metabolic disorders
GB0904284D0 (en)	2009-04-22	Compounds for the treatment of metabolic disorders
ZA201001705B (en)	2010-12-29	Azithromycin for treatment of skin disorders
PL1982178T3 (en)	2014-02-28	Methods for the treatment of affective disorders
GB0809476D0 (en)	2008-07-02	Treatment of neurodegenerative disorders
ZA201202347B (en)	2015-11-25	Therapeutic agent for anxiety disorders
IL210558A0 (en)	2011-03-31	Treatment of anxiety disorders
EP2164494A4 (en)	2010-06-02	Methods of treatment
IL209417A0 (en)	2011-01-31	1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders
EP2099444A4 (en)	2012-11-07	Use of d-serine derivatives for the treatment of anxiety disorders
GB0723100D0 (en)	2008-01-02	Treatment of HFnEF
SI2278962T1 (en)	2014-05-30	Methods for the treatment of dermatological disorders
ZA201100325B (en)	2012-04-25	Treatment of anxiety disorders
GB0819446D0 (en)	2008-12-03	Treatment of inflammatory disorders
GB0808623D0 (en)	2008-06-18	Treatment of keratinizing disorders
EP2124957A4 (en)	2011-07-27	Methods of treating mood disorders
GB0814043D0 (en)	2008-09-10	The treatment of skin disorders
GB0701715D0 (en)	2007-03-07	Treatment of bowel disorders

Legal Events

Date	Code	Title	Description
2008-10-29	AT	Applications terminated before publication under section 16(1)